#Japan #Tokyo #TCB #Hisaaki Munakata #IMCAS Asia

TCB's Contribution to Cosmetic Surgery at IMCAS Asia 2025

In the realm of aesthetic medicine, breakthroughs are vital to refining treatment techniques and improving patient outcomes, especially for specific age demographics. Dr. Hisaaki Munakata, director of TCB Tokyo Central Cosmetic Surgery, made a significant impact during his presentation at the prominent IMCAS Asia 2025 conference, held from June 6 to June 8 in Bangkok, Thailand.

The conference, recognized as one of the largest international gatherings for cosmetic medicine, attracted over 3,318 participants, highlighted by a series of 310 speakers discussing various advancements in aesthetics and surgery. Among the multitude of presentations, Dr. Munakata's focus on the midterm outcomes of the buried double eyelid surgery for middle-aged and elderly patients stood out, affirming TCB's commitment to enhancing surgical practices.

Surgical Insights from the UMEDA Study

Under the program titled FACE SURGERY: Blepharoplasty, Dr. Munakata presented findings from the UMEDA study, which investigated the efficacy of double eyelid surgery on patients experiencing dermatochalasis (loose skin around the eyelids).

The study comprised a comparative analysis between two demographics: 291 women over the age of 45 and 530 younger women aged between 18 and 39. As the aging process often brings with it concerns such as skin laxity, the research aimed to understand how buried suture methods fared in older patients compared to their younger counterparts.

Despite dominant practices favoring skin excision for those with significant skin sagging, the study results revealed that buried double eyelid surgery still serves as a valuable option. Within an average follow-up period of 9.5 months, the event rate (which included reoperation or removal of sutures for any reason) was 15.6% in the older cohort, compared to 7.2% in the younger group. Most notably, the cumulative event rate after 12 months showed 17.2% for older patients, still revealing a lesser occurrence than previously anticipated.

While the percentage indicates a higher complication rate in the older demographic, Dr. Munakata firmly positions this surgical approach as a sound option for those seeking aesthetic enhancements despite age-related skin challenges. The presentation underscored the importance of understanding the unique surgical needs of middle-aged and elderly patients.

TCB's Ongoing Research Endeavors

TCB Tokyo Central Cosmetic Surgery continues to set benchmarks in the cosmetic surgery field, boasting 105 clinics across Japan as of July 2025. Their motto, ‘To make beauty a source of happiness,’ aims to provide a range of aesthetic solutions with minimal physical strain, particularly through innovative procedures and solutions tailored to the aging population. Dr. Munakata’s recent findings join a list of scholarly contributions from TCB that emphasize research-led advancements in cosmetic surgery.

Interestingly, prior studies conducted by TCB include various topics, ranging from ideal nasal angles among the Japanese to complications arising from hyaluronic acid fillers. Each research effort aims to better understand and refine aesthetic preferences and safety, ensuring that procedures not only meet aesthetic goals but also prioritize patient well-being.

Conclusion

With continued advancements in techniques and research focused on specific patient profiles, TCB remains at the forefront of transforming the landscape of cosmetic surgery in Japan. The insights shared by Dr. Hisaaki Munakata at IMCAS Asia 2025 underscore a growing understanding of how to successfully cater to the needs of aging patients, reaffirming TCB’s role as a leader in innovative surgical practices. The cosmetic surgery community is charged with the crucial task of adapting to this demographic shift, and TCB is setting the standard by continually engaging in evidence-based practices that enhance aesthetic outcomes.